Biopolymer-based functional composites for medical applications
Over the last decade, numerous biopolymers have received more attention in medical
applications involving novel biomaterials because of their biocompatibility, biodegradability …
applications involving novel biomaterials because of their biocompatibility, biodegradability …
Drug-releasing implants: current progress, challenges and perspectives
The need for more efficient drug delivery strategies to treat resilient diseases and the rise of
micro and nanotechnology have led to the development of more sophisticated drug …
micro and nanotechnology have led to the development of more sophisticated drug …
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical …
PW Serruys, Y Onuma, D Dudek, PC Smits… - Journal of the American …, 2011 - jacc.org
Objectives: The aim of this study was to demonstrate that the prevention of early scaffold
area shrinkage of the ABSORB BVS (Rev. 1.1, Abbott Vascular, Santa Clara, California) was …
area shrinkage of the ABSORB BVS (Rev. 1.1, Abbott Vascular, Santa Clara, California) was …
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical …
PW Serruys, Y Onuma, JA Ormiston, B de Bruyne… - Circulation, 2010 - Am Heart Assoc
Background—The first generation of the bioresorbable everolimus drug-eluting vascular
scaffold showed signs of shrinkage at 6 months, which largely contributed to late luminal …
scaffold showed signs of shrinkage at 6 months, which largely contributed to late luminal …
Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents: Igaki-Tamai Stents
S Nishio, K Kosuga, K Igaki, M Okada, E Kyo, T Tsuji… - Circulation, 2012 - Am Heart Assoc
Background—The purpose of this study was to evaluate the long-term safety of the Igaki-
Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid …
Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid …
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study
JA Ormiston, PW Serruys, Y Onuma… - Circulation …, 2012 - Am Heart Assoc
Background—Nonserial observations have shown this bioresorbable scaffold to have no
signs of area reduction at 6 months and recovery of vasomotion at 1 year. Serial …
signs of area reduction at 6 months and recovery of vasomotion at 1 year. Serial …
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque …
Aims To analyse the vasoreactivity of a coronary segment, previously scaffolded by the
ABSORB bioresorbable vascular scaffold (BVS) device, in relationship to its intravascular …
ABSORB bioresorbable vascular scaffold (BVS) device, in relationship to its intravascular …
Assessing bioresorbable coronary devices: methods and parameters
HM Garcia-Garcia, PW Serruys, CM Campos… - JACC: Cardiovascular …, 2014 - jacc.org
Bioresorbable vascular scaffolds (BRS) represent a novel approach to provide transient
vessel support to drug-delivery capability without the long-term limitations of metallic drug …
vessel support to drug-delivery capability without the long-term limitations of metallic drug …
[HTML][HTML] Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal …
CV Bourantas, PW Serruys… - …, 2015 - eurointervention.pcronline.com
Aims: To evaluate the implications of an Absorb bioresorbable vascular scaffold (Absorb
BVS) on the morphology of the superficial plaques. Methods and results: Forty-six patients …
BVS) on the morphology of the superficial plaques. Methods and results: Forty-six patients …
Absorbable stent: focus on clinical applications and benefits
N Gonzalo, C Macaya - Vascular health and risk management, 2012 - Taylor & Francis
Coronary stents have improved very significantly the immediate and long-term results of
percutaneous coronary interventions. However, once the vessel has healed, the scaffolding …
percutaneous coronary interventions. However, once the vessel has healed, the scaffolding …